AstraZeneca, Pfizer Inc., and Novartis AG Spearhead Innovation in Tuberculosis Therapeutics Amid Rising Global Prevalence
July 20, 2023 05:18 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Active TB, Latent TB), By Therapy, By Route Of...
Global Idiopathic Pulmonary Fibrosis (IPF) Market to 2029: Players Include Boehringer Ingelheim, F. Hoffmann-La Roche, Cipla and Shionogi & Co
July 13, 2023 04:33 ET
|
Research and Markets
Dublin, July 13, 2023 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration...
Global Asthma & COPD Therapies Market Report 2023-2033: Expansion into Emerging Markets to Offer Lucrative Growth Opportunities
June 28, 2023 04:38 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Asthma & COPD Therapies Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Asthma & COPD Therapies Market...
Global Idiopathic Pulmonary Fibrosis Market Report 2023: Sector is Expected to Reach $7.52 Billion by 2030 at a CAGR of 8.7%
June 15, 2023 08:03 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market, By Drug, By Route of Administration, By Distribution Channel, and By Geography - Size, Share, Outlook, and...
Bronchodilators Global Market Report 2023: Sector to Reach $45 Billion by 2030 at a 4.7% CAGR
June 15, 2023 04:38 ET
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bronchodilators Market to Reach...
Global Bronchodilators Market to 2030: Increasing Prevalence of Lung Diseases Drives Growth
June 06, 2023 06:28 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators Market Size, Share & Trends Analysis Report By Disease (Asthma, COPD), By Route Of Administration (Inhalable, Oral), By Drug Class...
Global Respiratory Disease Partnering Analysis Report 2023: Deal Trends, Players and Financials for Deals Signed Since 2010
June 01, 2023 08:53 ET
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.Global...
Global Cystic Fibrosis Treatment Market Report 2023: Featuring AbbVie, Chiesi Farmaceutici, Novartis, Pharmaxis, AstraZeneca & More
May 24, 2023 06:33 ET
|
Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global market...
Global Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment Report 2023: Currently, There are 2 Leading Marketed Drugs with Roche and Boehringer Ingelheim Being Key Players
May 16, 2023 11:33 ET
|
Research and Markets
Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis (IPF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape" report has been added to ...
Global Sodium Citrate Market Report 2023: Sector is Expected to Reach $1.2 Billion by 2031 at a 4.09% CAGR
May 12, 2023 09:18 ET
|
Research and Markets
Dublin, May 12, 2023 (GLOBE NEWSWIRE) -- The "Sodium Citrate Market by Type, Application: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ...